SE8302027L - Forfarande for framstellning av 3,7-disubstituerade 3 cefem-4-karboxylsyraforeningar - Google Patents

Forfarande for framstellning av 3,7-disubstituerade 3 cefem-4-karboxylsyraforeningar

Info

Publication number
SE8302027L
SE8302027L SE8302027A SE8302027A SE8302027L SE 8302027 L SE8302027 L SE 8302027L SE 8302027 A SE8302027 A SE 8302027A SE 8302027 A SE8302027 A SE 8302027A SE 8302027 L SE8302027 L SE 8302027L
Authority
SE
Sweden
Prior art keywords
protected
cefem
disubstituted
preparing
procedure
Prior art date
Application number
SE8302027A
Other languages
English (en)
Other versions
SE8302027D0 (sv
SE454988B (sv
Inventor
T Kamiya
K Tanaka
Y Nakai
K Sakane
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9425/76A external-priority patent/GB1575803A/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of SE8302027D0 publication Critical patent/SE8302027D0/sv
Publication of SE8302027L publication Critical patent/SE8302027L/sv
Publication of SE454988B publication Critical patent/SE454988B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/50—Nitrogen atoms bound to hetero atoms
    • C07D277/52—Nitrogen atoms bound to hetero atoms to sulfur atoms, e.g. sulfonamides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (1)

PATENTKRAV
1. FOrening med formeln R1 van i Ri Sr amino, ldgre alkylamino, skyddad amino, eller skyddad lagre alkylamino, R Sr rate eller halogen, och RS Sr karboxi eller skyddad karboxl, eller ett salt dSrav.
SE8302027A 1976-03-09 1983-04-12 (2 ev. sub. amino -1,3-tiazol-5-yl)-glyoxylsyra derivat till anvendning som mellanprodukt till motsvarande cefalosporinsyror SE454988B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9425/76A GB1575803A (en) 1976-03-09 1976-03-09 3,7 disubstituted 3 cephem 4 carboxylic acid compounds andprocesses for the preparation thereof
GB4114576 1976-10-04

Publications (3)

Publication Number Publication Date
SE8302027D0 SE8302027D0 (sv) 1983-04-12
SE8302027L true SE8302027L (sv) 1983-04-12
SE454988B SE454988B (sv) 1988-06-13

Family

ID=26242927

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7702547A SE437832B (sv) 1976-03-09 1977-03-07 Forfarande for framstellning av 3,7-disubstituerade-3-cefem-4-karboxylsyraforeningar
SE8302027A SE454988B (sv) 1976-03-09 1983-04-12 (2 ev. sub. amino -1,3-tiazol-5-yl)-glyoxylsyra derivat till anvendning som mellanprodukt till motsvarande cefalosporinsyror

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7702547A SE437832B (sv) 1976-03-09 1977-03-07 Forfarande for framstellning av 3,7-disubstituerade-3-cefem-4-karboxylsyraforeningar

Country Status (10)

Country Link
US (1) US4560765A (sv)
AR (2) AR218241A1 (sv)
CA (1) CA1218054A (sv)
DE (1) DE2760288A1 (sv)
DK (2) DK168863B1 (sv)
ES (5) ES456625A1 (sv)
HU (2) HU179016B (sv)
IE (1) IE44888B1 (sv)
MX (1) MX4658E (sv)
SE (2) SE437832B (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE55406B1 (en) * 1982-08-07 1990-09-12 Tanabe Seiyaku Co Novel cephalosporin compounds and preparation thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
US4093803A (en) * 1971-05-14 1978-06-06 Glaxo Laboratories Limited 7β-[2-Etherified oximino-2-(thienyl-, furyl- or pyridylacetamido)] cephalosporins
SE417968B (sv) * 1972-10-20 1981-04-27 Fujisawa Pharmaceutical Co Forfarande for framstellning av penamderivat
US4113940A (en) * 1973-03-15 1978-09-12 Fujisawa Pharmaceutical Co., Ltd. 7-amino 2-lower alkyl-2 or 3-cephem-4-carboxylic acid derivatives and processes for preparation thereof
JPS5119765A (en) * 1974-08-09 1976-02-17 Takeda Chemical Industries Ltd Aminochiazoorujudotaino seizoho
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
US4298606A (en) * 1974-12-19 1981-11-03 Takeda Chemical Industries, Ltd. Thiazolylacetamido compounds
DE2715385A1 (de) * 1976-04-14 1977-11-10 Takeda Chemical Industries Ltd Cephalosporinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel

Also Published As

Publication number Publication date
DK139691A (da) 1991-07-25
AR218241A1 (es) 1980-05-30
DK139691D0 (da) 1991-07-25
ES467635A1 (es) 1979-09-01
CA1218054A (en) 1987-02-17
MX4658E (es) 1982-07-19
HU176455B (en) 1981-03-28
ES476076A1 (es) 1979-05-16
SE8302027D0 (sv) 1983-04-12
ES476075A1 (es) 1979-05-16
SE454988B (sv) 1988-06-13
DE2760288A1 (sv) 1985-05-09
IE44888B1 (en) 1982-05-05
ES456625A1 (es) 1978-07-16
AR222010A1 (es) 1981-04-15
SE437832B (sv) 1985-03-18
US4560765A (en) 1985-12-24
DK168863B1 (da) 1994-06-27
SE7702547L (sv) 1977-09-10
DK101477A (da) 1977-09-10
IE44888L (en) 1977-09-09
ES476077A1 (es) 1979-05-16
HU179016B (en) 1982-08-28

Similar Documents

Publication Publication Date Title
ES8300112A1 (es) Un procedimiento para preparar compuestos de cefem .
ATE44954T1 (de) Carbostyrilderivat und verfahren zu seiner herstellung.
IE810108L (en) IMIDAZO £1,2-a| PYRIDINES
SE7907811L (sv) Azetidinylforening for framstellning av cefemforeningar och forfarande for dess framstellning
DE2963097D1 (en) Process for the preparation of beta-lactam derivatives, the novel derivatives so obtainable and pharmaceutical compositions containing them
IE37767B1 (en) Derivatives of 7beta-amino-cephem-3-ol-4-carboxylic acids
AU2727984A (en) Imidazole-ethanol and esters thereof
SE7907672L (sv) Mellanprodukter for framstellning av farmaceutiskt verdefulla cefalosporinforeningar
IL42513A (en) N-(1h-tetrazol-5-yl)-quinaldamide derivatives,their production and pharmaceutical compositions containing them
IE40052B1 (en) Indole derivatives
GB1285400A (en) Esters of substituted anthranilic acid
JPS5724369A (en) Pyrimidine derivative and its preparation
GB1364453A (en) Penicillanic and cepholosporanic acid derivatives
GB1531963A (en) Pyrido(1,2alpha)pyrimidine derivatives
DE1966850A1 (de) Synthetische penicilline und verfahren zu ihrer herstellung ausser alpha-sulfobenzylpenicillin
SE8302027L (sv) Forfarande for framstellning av 3,7-disubstituerade 3 cefem-4-karboxylsyraforeningar
ATE42295T1 (de) Penem-derivate, verfahren zu deren herstellung, ihre verwendung und pharmazeutische zusammensetzungen.
FI915570A0 (fi) Inklusionskomplex av 3 -morfolinosydnonimin eller dess salter eller dess tautomera isomerer, foerfarande foer deras framstaellning och farmaceutiska kompositioner innehaollande desamma.
IE43117L (en) Naphthacene derivatives
ATE120743T1 (de) Pyridoindolderivate und verfahren zu ihrer herstellung.
CA1181741A (en) Water soluble derivatives of cephalexin and process for their preparation
GB1490451A (en) Cephalosporin and penicillin antibiotics
SE8306298L (sv) 7beta-isotiazolyltioacetamido-7alfa-metoxicefalosporansyraderivat
KR850700244A (ko) 세팔로스포린 유도체 및 그 염의 제조방법
GB1426541A (en) Cephalosporanic derivatives process for their preparation and compositions incorporating them

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8302027-1

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8302027-1

Format of ref document f/p: F